![](https://news.europawire.eu/wp-content/uploads/2016/02/Merck-GROUP-LOGO.png)
Merck obtains global marketing and commercialization rights for the innovative Progyny Eeva® software offering, aiming to provide customers worldwide with innovative fertility technologies solutions This new agreement builds on the successful relationship between both leaders in fertility technologies, first established … Read the full press release